Inova Health’s Post

Learn more about #LungHealth from our national partners - American Lung Association during #NationalRadonActionMonth! Radon gas is the leading cause of #lungcancer among non-smokers, so testing for radon in the places we live, work, and learn is an essential part of taking care of your community's health. Because symptoms of radon gas poisoning typically don't show up until they present as lung cancer, it's crucial to be proactive about taking care of dangerous indoor radon levels right away. Test your buildings for #radon to reveal your exposure level as the first step to keeping your stakeholders breathing safe air. lung.org #indoorairquality #radonactionmonth #toxicgas #january2024 #safety #propertyowners

In this video, advisory board member Dr. Veeral Sheth, MD, MBA, FASRS, FACS describes the presentation of #GeographicAtrophy in patients and how they are first affected by the disease. https://lnkd.in/eesX_DJ3 #Ophthalmology 

With our understanding of interstitial lung disease our knowledge,attitude and practice towards this disease has made tectonic shifts. This video is for all those of you who have known someone with intersitial lung disease and general overview of how we go about managing it. #ILD #intersitiallungdisease #aster #asterdmhealthcare #lungtransplant #interventionalpulmonology #IPF #Hypersensitivitypneumonitis #CTD #MDT #bangalore #whitefield

🚨 January is Radon Action Month 🚨 Join Body Vision and @The American Lung Association in fighting the invisible threat! Radon is a naturally occurring, invisible, odorless gas that can have serious health consequences, including lung cancer. In fact, in the US it's the ☣ 2nd leading cause of lung cancer, ☣ making radon testing more crucial than ever. At Body Vision Medical, we're dedicated to preventing lung disease at the source. We stand with the American Lung Association in recommending that everyone tests their homes for radon, taking action if dangerous levels are identified. 🔎 Testing for radon is easy, and addressing high levels can significantly reduce health risks. 📣 Let's take action to ensure our homes are safe and support a healthier future for all by spreading the word! How are you supporting Radon Action Month? Share your stories, tips, or plans for radon testing and mitigation in your homes or communities. Check out our page and hit "Follow" to stay ahead of the curve ⤴ #RadonActionMonth #LungHealth #PreventativeHealthcare #pulmonology

🌍✨ Honoring World Sickle Cell Day: Advocating for Awareness and Support ✨🌍 On this significant day, June 19, 2024, we come together to shine a light on World Sickle Cell Day. This day serves as a global platform to raise awareness about sickle cell disease, a genetic condition that affects millions worldwide. Let us take a moment to recognize the challenges faced by individuals living with sickle cell disease – from the daily battles with pain and complications to the need for greater access to specialized care and support. It is crucial that we stand in solidarity with the sickle cell community, amplifying their voices and advocating for improved resources and healthcare services. As we commemorate World Sickle Cell Day, let us commit to fostering a culture of understanding, empathy, and action. By increasing awareness, supporting research initiatives, and advocating for equitable access to care, we can make a meaningful difference in the lives of those affected by this condition. Together, let us be a force for positive change, driving towards a future where every individual with sickle cell disease receives the care, support, and respect they deserve. Join us in raising awareness, spreading compassion, and standing united in the fight against sickle cell disease. #WorldSickleCellDay #SickleCellAwareness #HealthEquity #SupportSickleCellWarriors #GlobalHealth #RaiseAwareness Together, we can make a difference. 💙 Francis 🩸

Tonight at 18:00 CEST: Challenging cases in interstitial lung disease: solving mysteries This case-based webinar will see the experts discuss the most challenging case studies in the field of interstitial lung disease (ILD), and how to manage them. Find out more and register now: https://lnkd.in/ed5iq2zU

To mark Rare Disease Day 2024, this week we are exploring four critical elements to sustaining rare disease innovation in Europe. Today focuses on requirement #3: Supportive P&R. Whether a medicine exists matters little for patients who cannot receive it because it is not reimbursed. Reimbursement is also key for manufacturers who rely on the sale of medicines to recover their considerable investment in development and to support their future pipeline. Continued innovation and access in rare disease in Europe relies on country-level pricing and reimbursement (P&R) approaches that can recognise and reward promising orphan developments. But this is by no means simple since many extremely novel, transformative treatments fall foul of traditional P&R systems designed for chronic therapies in common conditions. One example is cell and gene therapies. These unique treatments present immense value owing to their one-time, potentially curative profile. They also come with a significant price tag, complex delivery, and an inevitable degree of uncertainty around long-term benefit. In our recent paper for the Alliance for Regenerative Medicines (ARM), Dolon's Managing Director, Adam Hutchings, explores these challenges and their implications for P&R, patient access, and the sustainability of ATMP innovation in Europe. In particular, we focus on innovative contracting as an opportunity to mitigate these challenges as well as recent learnings from manufacturers’ experience in negotiating these. P&R frameworks need to evolve with science if they are to fully reflect the value of emerging therapies to patients and health systems alike. Failure to do so will come at the expense of patients and health systems today, and Europe’s standing as a global centre for innovation in the longer term. Read on to learn more: https://bit.ly/42UC0Uf #RareDiseaseDay2024 #RareDiseaseDay #RDD2024 #LightUpForRare #ShareYourColours #RareDiseases #RareDiseaseAwareness #RareDiseaseInnovation #Dolon

🗓Mark in your agenda one of the first top appointments of the first working day at the #JIMCongress2024!🚀 On March 21st, our coordinators Antonio Colombo and Giuseppe Tarantini MD, PhD will conduct 2️⃣ interesting LIVE CASEs focused on: CORONARY ARTERY DISEASE IN CHALLENGING SCENARIOS! 💥 Check below for the highlights!⤵️ #InterventionalCardiology

Our latest paper is out !!! It provides the first preclinical evidence indicating that repurposing of Montelukast, a safe and marketed anti-asthmatic drug, may be a promising sex-specific strategy for personalized ALS treatment ! #ALS#Monteukast

Learn how an innovation in 3D bioprinting using a new mucus-based bioink is paving the way for functional lung tissue creation and offering hope for chronic lung disease treatment and research. https://lnkd.in/e_GS-9B7